Abdelnabi, Mahmoud

Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy

Journal of the American Heart Association | March 4, 2026 | Volume: 15 | Issue: 6 | Pages: No page available

10.1161/jaha.125.045649 | PMID 41778598